QA: Akorn INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000003116_2019_Akorn_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000003116, Akorn INC

  xvar xval
0 AssetsCurrent 583,819,000
1 IntangibleAssetsNetIncludingGoodwill 568,855,000
2 PropertyPlantAndEquipmentNet 334,853,000
3 remainder_Assets 7,730,000
4 LiabilitiesCurrent 170,823,000
5 LiabilitiesNoncurrent 880,568,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 507,252,279
8 SellingGeneralAndAdministrativeExpense 480,950,839
9 ResearchAndDevelopmentExpense 59,121,430
10 remainder_Expenses 232,849,539
11 remainder_Revenues 511,905,458
12 remainder_NetIncome -45,124,255
13 remainder_ComprehensiveNetIncome 7,968,716
  yvar yval
0 Assets 1,495,257,000
1 Liabilities 1,051,391,000
2 Expenses 1,280,174,087
3 Revenues 511,905,458
4 StockholdersEquity 443,866,000
5 NetIncome -813,392,884
6 ComprehensiveNetIncome -809,408,526
7 BaseVar 2,195,910,258
8 EconomicCapitalRatiobeforeLimitedLiability 0.124
9 EconomicCapitalRatio 1.53

Edgar->Model Mapping

Feature Distribution

Change over Time